Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc....

FDA Recall #D-0149-2025 — Class II — December 6, 2024

Recall #D-0149-2025 Date: December 6, 2024 Classification: Class II Status: Ongoing

Product Description

Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520. NDC: 59651-137-30

Reason for Recall

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.

Recalling Firm

Aurobindo Pharma USA Inc — East Windsor, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Distribution

Nationwide in the USA

Code Information

Lot #: NB0224001A and NB0224001B, Exp. Date 04/2027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated